(Q40468893)

20 September 2017

Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. (English)

1 reference

20 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Suk-Yong Jang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Yong-Ho Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Chung Mo Nam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Eun Seok Kang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Eugene Han

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Se-Young Park

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

7 November 2016

1 reference

International Journal of Cancer

20 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

798-806

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

Primary liver cancer: worldwide incidence and trends

5 June 2020

cites work

1 reference

Hepatocellular carcinoma: epidemiology, risk factors, and screening

21 January 2018

1 reference

Hepatocellular carcinoma epidemiology

21 January 2018

1 reference

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

21 January 2018

1 reference

Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

21 January 2018

1 reference

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

21 January 2018

1 reference

Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies

21 January 2018

1 reference

Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population

21 January 2018

1 reference

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis

21 January 2018

1 reference

Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus

21 January 2018

1 reference

Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010.

21 January 2018

1 reference

Statins and cancer prevention

21 January 2018

1 reference

Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink

21 January 2018

1 reference

Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection

21 January 2018

1 reference

Statins and primary liver cancer: a meta-analysis of observational studies.

21 January 2018

1 reference

Statin use and risk of liver cancer: an update meta-analysis

21 January 2018

1 reference

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) and genetic variability (single nucleotide polymorphisms) in a hepatic drug uptake transporter: what's it all about?

21 January 2018

1 reference

Statins: mechanism of action and effects.

21 January 2018

1 reference

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

21 January 2018

1 reference

Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea

21 January 2018

1 reference

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

21 January 2018

1 reference

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

21 January 2018

1 reference

Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.

21 January 2018

1 reference

Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study

21 January 2018

1 reference

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

21 January 2018

1 reference

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy

21 January 2018

1 reference

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

21 January 2018

1 reference

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis

21 January 2018

1 reference

The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives

21 January 2018

1 reference

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

21 January 2018

1 reference

Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction

21 January 2018

1 reference

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

21 January 2018

1 reference

The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease.

21 January 2018

1 reference

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27861855%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference